Meilleure Health International Industry Group Limited
SEHK:2327 Stock Report
Market Cap: HK$1.0b
Meilleure Health International Industry Group Valuation
Is 2327 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 2327 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 2327 (HK$0.26) is trading below our estimate of fair value (HK$0.26)
Significantly Below Fair Value: 2327 is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2327?
Key metric: As 2327 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for 2327. This is calculated by dividing 2327's market cap by their current
earnings.
What is 2327's PE Ratio?
PE Ratio
33.5x
Earnings
HK$31.14m
Market Cap
HK$1.04b
2327 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: 2327 is expensive based on its Price-To-Earnings Ratio (33.5x) compared to the Hong Kong Trade Distributors industry average (10.4x).
Price to Earnings Ratio vs Fair Ratio
What is 2327's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
2327 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
33.5x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 2327's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.